The company, which sells direct-to-consumer genetic tests, unveils a new health-related report and a brand-new web experience.
Big news at 23andMe today: The direct-to-consumer genetics company is selling health-related genetic tests again—starting with one category of disorders, autosomal recessive disorders that children can inherit if both their parents are carriers. The new test comes with a higher price tag of $199 for new customers, up from $99 before the FDA told the health startup to stop marketing its genetic health tests two years ago. 23andMe is also unveiling a revamped web experience it hopes will help customers better understand their genetic health reports.
